TR201716207A2 - Pharmaceutical formulations containing vilanterol and umeclidinium. - Google Patents
Pharmaceutical formulations containing vilanterol and umeclidinium. Download PDFInfo
- Publication number
- TR201716207A2 TR201716207A2 TR2017/16207A TR201716207A TR201716207A2 TR 201716207 A2 TR201716207 A2 TR 201716207A2 TR 2017/16207 A TR2017/16207 A TR 2017/16207A TR 201716207 A TR201716207 A TR 201716207A TR 201716207 A2 TR201716207 A2 TR 201716207A2
- Authority
- TR
- Turkey
- Prior art keywords
- umeclidinium
- vilanterol
- pharmaceutical formulations
- formulations containing
- dry powder
- Prior art date
Links
- FVTWTVQXNAJTQP-UHFFFAOYSA-N diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol Chemical compound C=1C=CC=CC=1C(C12CC[N+](CCOCC=3C=CC=CC=3)(CC1)CC2)(O)C1=CC=CC=C1 FVTWTVQXNAJTQP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229960004258 umeclidinium Drugs 0.000 title abstract 2
- DAFYYTQWSAWIGS-DEOSSOPVSA-N vilanterol Chemical compound C1=C(O)C(CO)=CC([C@@H](O)CNCCCCCCOCCOCC=2C(=CC=CC=2Cl)Cl)=C1 DAFYYTQWSAWIGS-DEOSSOPVSA-N 0.000 title abstract 2
- 229960004026 vilanterol Drugs 0.000 title abstract 2
- 239000000843 powder Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, Vilanterol ve Umeklidinyumdan oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.The present invention relates to pharmaceutical formulations in dry powder form comprising Vilanterol and Umeclidinium for use in respiratory tract ailments.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/16238A TR201716238A1 (en) | 2017-10-18 | 2017-10-20 | New pharmaceutical compositions. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (en) | 2017-10-20 | 2017-10-20 | New umeclidinium formulations. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201716207A2 true TR201716207A2 (en) | 2019-05-21 |
Family
ID=67954794
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16209A TR201716209A2 (en) | 2017-09-30 | 2017-10-20 | New pharmaceutical compositions containing arformoterol and umeclidinium. |
| TR2017/16203A TR201716203A1 (en) | 2017-09-30 | 2017-10-20 | New umeclidinium formulations. |
| TR2017/16207A TR201716207A2 (en) | 2017-10-18 | 2017-10-20 | Pharmaceutical formulations containing vilanterol and umeclidinium. |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16209A TR201716209A2 (en) | 2017-09-30 | 2017-10-20 | New pharmaceutical compositions containing arformoterol and umeclidinium. |
| TR2017/16203A TR201716203A1 (en) | 2017-09-30 | 2017-10-20 | New umeclidinium formulations. |
Country Status (1)
| Country | Link |
|---|---|
| TR (3) | TR201716209A2 (en) |
-
2017
- 2017-10-20 TR TR2017/16209A patent/TR201716209A2/en unknown
- 2017-10-20 TR TR2017/16203A patent/TR201716203A1/en unknown
- 2017-10-20 TR TR2017/16207A patent/TR201716207A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR201716203A1 (en) | 2019-05-21 |
| TR201716209A2 (en) | 2019-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125595T1 (en) | DRY POWDER PREPARATION CONTAINING A CORTICOSTEROID AND A BETA-ADRENERGENT FOR INHALATION | |
| HUE061174T2 (en) | 1,3,4-oxadiazolesulfonamide derivative compounds as histone deacetylase-6 inhibitors and pharmaceutical preparations containing such compounds | |
| MX378273B (en) | ACTIVE COMPOUNDS TOWARDS BROMODOMAINS. | |
| DOP2017000306A (en) | PHARMACEUTICAL FORMULATIONS CONTAINING TENOFOVIR AND EMTRICITABINE | |
| MX388733B (en) | ANTIFUNGAL DRY POWDERS. | |
| IL283539A (en) | 3,3-difluoroallylamines or their salts and pharmaceutical preparations containing them | |
| WO2016140933A3 (en) | Immediate release soluble ibuprofen compositions | |
| MX389178B (en) | FIXED RATIO FORMULATION OF INSULIN GLARGINE/LIXISENATIDE. | |
| DK3429559T3 (en) | Palatable compositions containing sodium phenylbutyrate and uses thereof | |
| HUE057871T2 (en) | Hyaluronan conjugates, methods and compositions containing medicinal active ingredients | |
| IL313924A (en) | Pharmaceutical dry powder formulation for inhalation | |
| CO2018014217A2 (en) | Pharmaceutical compositions comprising safinamide | |
| PH12018502139A1 (en) | Phosphaplatin liquid formulations | |
| MX393915B (en) | NEW ORAL FORMULATIONS OF BELINOSTAT. | |
| EP3623384A4 (en) | ANTI-CLDN-5 ANTIBODIES, AND THE MEDICINAL PRODUCT CONTAINING IT | |
| MX2018009948A (en) | Oritavancin formulations. | |
| EA201891848A1 (en) | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF FIBROSIS | |
| LT3097921T (en) | COMPOSITIONS INCLUDING GERANIOL AND DRY GINGER FOR USE IN THE TREATMENT OF IRRITANT GUT SYNDROME | |
| TR201714725A1 (en) | DRY POWDER FORMULATION WITH BETA-2 AGONIST AND ANTICOLINERGIC | |
| TR201714728A1 (en) | Dry powder formulation containing Beta-2 Agonist and Corticosteroid. | |
| CO2020006552A2 (en) | Pharmaceutical compositions comprising safinamide | |
| TR201714893A1 (en) | Dry powder composition containing Beta-2 Agonist and Corticosteroid. | |
| LV15003A (en) | A pharmaceutical composition for the control of weight gain | |
| EA202091403A1 (en) | 2-OXO-1-PYRROLIDINYLIMIDAZOTHIAZOLE DERIVATIVES | |
| TR201716155A1 (en) | Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. |